EPCAM and breast cancer: In vitro assessments showed higher cellular toxicity and cellular internalization of Apt-Pep@MUA.GNR-DOX in EpCAM overexpressing breast cancer cell lines (4T1 and MCF-7) in comparison with that of Pep@MUA.GNR-DOX.